APA (7th ed.) Citation

LL, H., YY, H., J, Y., XN, L., JS, M., WC, W., . . . YH, B. (2025). Mitigation of Ferroptosis in Diabetic Kidney Disease Through Mesenchymal Stem Cell Intervention via the Smad2/3/METTL3/S1PR1 Axis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 39(12), e70714. https://doi.org/10.1096/fj.202403207R

Chicago Style (17th ed.) Citation

LL, Huang, Hou YY, Yang J, Liao XN, Ma JS, Wang WC, Quan YX, Jiang HY, and Bai YH. "Mitigation of Ferroptosis in Diabetic Kidney Disease Through Mesenchymal Stem Cell Intervention via the Smad2/3/METTL3/S1PR1 Axis." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 39, no. 12 (2025): e70714. https://doi.org/10.1096/fj.202403207R.

MLA (9th ed.) Citation

LL, Huang, et al. "Mitigation of Ferroptosis in Diabetic Kidney Disease Through Mesenchymal Stem Cell Intervention via the Smad2/3/METTL3/S1PR1 Axis." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 39, no. 12, 2025, p. e70714, https://doi.org/10.1096/fj.202403207R.